DexCom (NASDAQ:DXCM – Get Free Report) was upgraded by equities researchers at UBS Group to a “strong-buy” rating in a research report issued to clients and investors on Tuesday,Zacks.com reports. Weiss Ratings lowered DexCom from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday. Finally, Canaccord Genuity Group set a $82.00 price objective on shares of DexCom and gave the company a “buy” rating in a research report on Monday, May 18th. Three research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, DexCom presently has an average rating of “Moderate Buy” and an average target price of $85.40.